September 2020 Briefing – Pathology

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 21 to 25, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.

Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article

U.S. Non-English Speakers Less Likely to Have SARS-CoV-2 Test

FRIDAY, Sept. 25, 2020 (HealthDay News) — Non-English speakers are less likely to have completed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and have a higher proportion of positive tests compared with English speakers, according to a research letter published online Sept. 24 in JAMA Network Open.

Abstract/Full Text

One-Fifth of Those With SARS-CoV-2 Infection Asymptomatic

FRIDAY, Sept. 25, 2020 (HealthDay News) — About one-fifth of individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are asymptomatic and their viral load is comparable to that of patients with mild symptoms, according to a study published online Sept. 22 in Thorax.

Abstract/Full Text

Fertility Treatment Cancellations Due to COVID-19 Impact Mental Health

FRIDAY, Sept. 25, 2020 (HealthDay News) — Fertility treatment suspensions due to the COVID-19 pandemic have had a considerable negative impact on women’s mental health and quality of life, according to a study published online Sept. 18 in PLOS ONE.

Abstract/Full Text

Performance of Commercial SARS-CoV-2 Ab Tests Varies

FRIDAY, Sept. 25, 2020 (HealthDay News) — There is considerable variation in the performance of commercial kits for detecting antibodies against SARS-CoV-2, according to a study published online Sept. 24 in PLOS Pathogens.

Abstract/Full Text

Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021

THURSDAY, Sept. 24, 2020 (HealthDay News) — A Chinese pharmaceutical company claims its COVID-19 vaccine should available by early next year for distribution in the United States and other countries.

AP News Article

United First U.S. Airline to Offer COVID-19 Testing for Passengers

THURSDAY, Sept. 24, 2020 (HealthDay News) — The first COVID-19 testing program for airline passengers in the United States will be introduced Oct. 15 by United Airlines.

CBS News Article

Genetically Predicted BMI Increases Rheumatoid Arthritis Risk

WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Genetically predicted body mass index (BMI) significantly increases the risk for rheumatoid arthritis (RA), according to a study published online Sept. 22 in Arthritis & Rheumatology.